Skip to main content
Top
Published in: Forensic Toxicology 1/2019

01-01-2019 | Letter to the Editor

Use of polysaccharide-based chiral columns: enantiomeric separation of seven pairs of abused drugs by high-performance liquid chromatography–mass spectrometry

Authors: Tajudheen K. Karatt, Abdul Khader Karakka Kal, Ramy Sayed, Jahfar Nalakath, Zubair Perwad

Published in: Forensic Toxicology | Issue 1/2019

Login to get access

Excerpt

Dear Editor
Literature
3.
4.
6.
go back to reference Craig CR, Stitzel RE (2004) Modern pharmacology with clinical applications, 6th edn. Lippincott Williams & Wilkins, Philadelphia Craig CR, Stitzel RE (2004) Modern pharmacology with clinical applications, 6th edn. Lippincott Williams & Wilkins, Philadelphia
7.
go back to reference Godwin M, Dawes M (2004) Intra-articular steroid injections for painful knees. Systematic review with meta-analysis. Can Fam Physician 50:241–248PubMedPubMedCentral Godwin M, Dawes M (2004) Intra-articular steroid injections for painful knees. Systematic review with meta-analysis. Can Fam Physician 50:241–248PubMedPubMedCentral
8.
9.
go back to reference Brater DC (1983) Pharmacodynamic considerations in the use of diuretics. Annu Rev Pharmacol Toxicol 23:45–62CrossRefPubMed Brater DC (1983) Pharmacodynamic considerations in the use of diuretics. Annu Rev Pharmacol Toxicol 23:45–62CrossRefPubMed
10.
go back to reference Goyal RK, Hirano I (1996) Mechanisms of disease: the enteric nervous system. N Engl J Med 334:1106–1115CrossRefPubMed Goyal RK, Hirano I (1996) Mechanisms of disease: the enteric nervous system. N Engl J Med 334:1106–1115CrossRefPubMed
11.
go back to reference Majewski H (1983) Modulation of noradrenaline release through activation of presynaptic β-adrenoreceptors. J Auton Pharmacol 3:47–60CrossRefPubMed Majewski H (1983) Modulation of noradrenaline release through activation of presynaptic β-adrenoreceptors. J Auton Pharmacol 3:47–60CrossRefPubMed
12.
go back to reference Davis E, Loiacono R, Summers RJ (2009) The rush to adrenaline: drugs in sport acting on the β-adrenergic system. Br J Pharmacol 154:584–597CrossRef Davis E, Loiacono R, Summers RJ (2009) The rush to adrenaline: drugs in sport acting on the β-adrenergic system. Br J Pharmacol 154:584–597CrossRef
13.
go back to reference Franchimont P, Gaspard U, Reuter A, Heynen G (1972) Polymorphism of protein and polypeptide hormones. Clin Endocrinol 4:315–336CrossRef Franchimont P, Gaspard U, Reuter A, Heynen G (1972) Polymorphism of protein and polypeptide hormones. Clin Endocrinol 4:315–336CrossRef
14.
go back to reference Ali I, Gupta VK, Aboul-Enein HY, Singh P, Sharma B (2007) Role of racemization in optically active drugs development. Chirality 19:453–463CrossRefPubMed Ali I, Gupta VK, Aboul-Enein HY, Singh P, Sharma B (2007) Role of racemization in optically active drugs development. Chirality 19:453–463CrossRefPubMed
15.
go back to reference Adams J (1993) Structure–activity and dose–response relationships in the neural and behavioral teratogenesis of retinoids. Neurotoxicol Teratol 15:193–202CrossRefPubMed Adams J (1993) Structure–activity and dose–response relationships in the neural and behavioral teratogenesis of retinoids. Neurotoxicol Teratol 15:193–202CrossRefPubMed
16.
go back to reference Agranat I, Caner H, Caldwell J (2002) Putting chirality to work: the strategy of chiral switches. Nat Rev Drug Discov 1:753–768CrossRefPubMed Agranat I, Caner H, Caldwell J (2002) Putting chirality to work: the strategy of chiral switches. Nat Rev Drug Discov 1:753–768CrossRefPubMed
17.
go back to reference Andrews JE, Ebron-McCoy M, Bojic U, Nau H, Kavlock RJ (1995) Validation of an in vitro teratology system using chiral substances: stereo selective teratogenicity of 4-yn-valproic acid in cultured mouse embryos. Toxicol Appl Pharmacol 132:310–316CrossRefPubMed Andrews JE, Ebron-McCoy M, Bojic U, Nau H, Kavlock RJ (1995) Validation of an in vitro teratology system using chiral substances: stereo selective teratogenicity of 4-yn-valproic acid in cultured mouse embryos. Toxicol Appl Pharmacol 132:310–316CrossRefPubMed
18.
go back to reference Anonymous (1997) Fenfluramine and dexfenfluramine withdrawn from market. Am J Health Syst Pharm 54:2260–2269 Anonymous (1997) Fenfluramine and dexfenfluramine withdrawn from market. Am J Health Syst Pharm 54:2260–2269
20.
go back to reference Cahn RS, Ingold C, Prelog V (1956) The specification of asymmetric configuration in organic chemistry. Experientia 12:81–94CrossRef Cahn RS, Ingold C, Prelog V (1956) The specification of asymmetric configuration in organic chemistry. Experientia 12:81–94CrossRef
21.
22.
go back to reference Tripathi K (1993) Drug enantiomers and their pharmacological implications. Ind J Pharmacol 25:73–77 Tripathi K (1993) Drug enantiomers and their pharmacological implications. Ind J Pharmacol 25:73–77
23.
24.
25.
go back to reference Ariens EJ (1984) Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol 26:663–668CrossRefPubMed Ariens EJ (1984) Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol 26:663–668CrossRefPubMed
27.
go back to reference Taschwer M, Grascher J, Schmid MG (2016) Development of an enantioseparation method for novel psychoactive drugs by HPLC using a Lux® Cellulose-2 column in polar organic phase mode. Forensic Sci Int 270:232–240CrossRefPubMed Taschwer M, Grascher J, Schmid MG (2016) Development of an enantioseparation method for novel psychoactive drugs by HPLC using a Lux® Cellulose-2 column in polar organic phase mode. Forensic Sci Int 270:232–240CrossRefPubMed
28.
go back to reference Hegstad S, Havnen H, Helland A, Spigset O, Frost J (2018) Enantiomeric separation and quantification of R/S-amphetamine in urine by ultra-high performance supercritical fluid chromatography tandem mass spectrometry. J Chromatogr B 1077-1078:7–12CrossRef Hegstad S, Havnen H, Helland A, Spigset O, Frost J (2018) Enantiomeric separation and quantification of R/S-amphetamine in urine by ultra-high performance supercritical fluid chromatography tandem mass spectrometry. J Chromatogr B 1077-1078:7–12CrossRef
29.
go back to reference Doi T, Tagami T, Takeda A, Asada A, Sawabe Y (2018) Evaluation of carboxamide-type synthetic cannabinoids as CB1/CB2 receptor agonists: difference between the enantiomers. Forensic Toxicol 36:51–60CrossRefPubMed Doi T, Tagami T, Takeda A, Asada A, Sawabe Y (2018) Evaluation of carboxamide-type synthetic cannabinoids as CB1/CB2 receptor agonists: difference between the enantiomers. Forensic Toxicol 36:51–60CrossRefPubMed
30.
go back to reference Karatt TK, Nalakath J, Perwad Z, Albert PH, Khader KKA, Padusha MSA, Laya S (2018) Mass spectrometric method for distinguishing isomers of dexamethasone via fragment mass ratio: an HRMS approach. J Mass Spectrom 53:1046–1058CrossRefPubMed Karatt TK, Nalakath J, Perwad Z, Albert PH, Khader KKA, Padusha MSA, Laya S (2018) Mass spectrometric method for distinguishing isomers of dexamethasone via fragment mass ratio: an HRMS approach. J Mass Spectrom 53:1046–1058CrossRefPubMed
31.
go back to reference Peng L, Jayapalan S, Chankvetadze B, Farkas T (2010) Reversed-phase chiral HPLC and LC/MS analysis with tris(chloromethylphenylcarbamate) derivatives of cellulose and amylose as chiral stationary phases. J Chromatogr A 1217:6942–6955CrossRefPubMed Peng L, Jayapalan S, Chankvetadze B, Farkas T (2010) Reversed-phase chiral HPLC and LC/MS analysis with tris(chloromethylphenylcarbamate) derivatives of cellulose and amylose as chiral stationary phases. J Chromatogr A 1217:6942–6955CrossRefPubMed
32.
go back to reference Tachibana K, Ohnishi A (2001) Reversed-phase liquid chromatographic separation of enantiomers on polysaccharide type chiral stationary phases. J Chromatogr A 906:127–154CrossRefPubMed Tachibana K, Ohnishi A (2001) Reversed-phase liquid chromatographic separation of enantiomers on polysaccharide type chiral stationary phases. J Chromatogr A 906:127–154CrossRefPubMed
33.
go back to reference Karatt TK, Sayed R, Nalakath J, Perwad Z, Albert PH, Abdul Khader KK (2018) Separation and identification of the epimeric doping agents—dexamethasone and betamethasone in equine urine and plasma: a reversed phase chiral chromatographic approach. Steroids 140:77–82CrossRefPubMed Karatt TK, Sayed R, Nalakath J, Perwad Z, Albert PH, Abdul Khader KK (2018) Separation and identification of the epimeric doping agents—dexamethasone and betamethasone in equine urine and plasma: a reversed phase chiral chromatographic approach. Steroids 140:77–82CrossRefPubMed
34.
go back to reference Barhate CL, Wahab MF, Breitbach ZS, Bell DS, Armstrong DW (2015) High efficiency, narrow particle size distribution, sub-2 μm based macrocyclic glycopeptide chiral stationary phases in HPLC and SFC. Anal Chim Acta 898:128–137CrossRefPubMed Barhate CL, Wahab MF, Breitbach ZS, Bell DS, Armstrong DW (2015) High efficiency, narrow particle size distribution, sub-2 μm based macrocyclic glycopeptide chiral stationary phases in HPLC and SFC. Anal Chim Acta 898:128–137CrossRefPubMed
35.
go back to reference Dolzan MD, Shu Y, Smuts JP, Petersen H, Ellegaard P, Micke GA, Armstrong DW, Breitbach ZS (2016) Enantiomeric separation of citalopram analogues by HPLC using macrocyclic glycopeptide and cyclodextrin based chiral stationary phases. J Liq Chromatogr Relat Technol 39:154–160CrossRef Dolzan MD, Shu Y, Smuts JP, Petersen H, Ellegaard P, Micke GA, Armstrong DW, Breitbach ZS (2016) Enantiomeric separation of citalopram analogues by HPLC using macrocyclic glycopeptide and cyclodextrin based chiral stationary phases. J Liq Chromatogr Relat Technol 39:154–160CrossRef
36.
go back to reference Kosel M, Eap CB, Amey M, Baumann P (1998) Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography. J Chromatogr B 719:234–238CrossRef Kosel M, Eap CB, Amey M, Baumann P (1998) Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography. J Chromatogr B 719:234–238CrossRef
37.
go back to reference Matthijs N, Perrin C, Maftouh M, Massart DL, Vander Heyden Y (2004) Definition and system implementation of strategies for method development of chiral separations in normal-or reversed-phase liquid chromatography using polysaccharide-based stationary phases. J Chromatogr A 1041:119–133CrossRefPubMed Matthijs N, Perrin C, Maftouh M, Massart DL, Vander Heyden Y (2004) Definition and system implementation of strategies for method development of chiral separations in normal-or reversed-phase liquid chromatography using polysaccharide-based stationary phases. J Chromatogr A 1041:119–133CrossRefPubMed
38.
go back to reference Padivitage NL, Dodbiba E, Breitbach ZS, Armstrong DW (2014) Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases. Drug Test Anal 6:542–551CrossRefPubMed Padivitage NL, Dodbiba E, Breitbach ZS, Armstrong DW (2014) Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases. Drug Test Anal 6:542–551CrossRefPubMed
39.
go back to reference Geryk R, Kalíková K, Vozka J, Tesarˇová E (2013) Immobilized polysaccharide-based stationary phases for enantioseparation in normal versus reversed phase HPLC. Chromatographia 76:483–489CrossRef Geryk R, Kalíková K, Vozka J, Tesarˇová E (2013) Immobilized polysaccharide-based stationary phases for enantioseparation in normal versus reversed phase HPLC. Chromatographia 76:483–489CrossRef
40.
go back to reference USP (1978) The United States Pharmacopeia, 20th revision. The United States Pharmacopeia, Washington, DC, p 943 USP (1978) The United States Pharmacopeia, 20th revision. The United States Pharmacopeia, Washington, DC, p 943
41.
go back to reference Perrin C, Vu VA, Matthijs N, Maftouh M, Massart DL, Vander Heyden Y (2002) Screening approach for chiral separation of pharmaceuticals: Part I. Normal-phase liquid chromatography. J Chromatogr A 947:69–83CrossRefPubMed Perrin C, Vu VA, Matthijs N, Maftouh M, Massart DL, Vander Heyden Y (2002) Screening approach for chiral separation of pharmaceuticals: Part I. Normal-phase liquid chromatography. J Chromatogr A 947:69–83CrossRefPubMed
Metadata
Title
Use of polysaccharide-based chiral columns: enantiomeric separation of seven pairs of abused drugs by high-performance liquid chromatography–mass spectrometry
Authors
Tajudheen K. Karatt
Abdul Khader Karakka Kal
Ramy Sayed
Jahfar Nalakath
Zubair Perwad
Publication date
01-01-2019
Publisher
Springer Japan
Published in
Forensic Toxicology / Issue 1/2019
Print ISSN: 1860-8965
Electronic ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-018-0453-6

Other articles of this Issue 1/2019

Forensic Toxicology 1/2019 Go to the issue